» Articles » PMID: 30111355

CSF H3F3A K27M Circulating Tumor DNA Copy Number Quantifies Tumor Growth and in Vitro Treatment Response

Citing Articles

Establishment of xenografts and methods to evaluate tumor burden for the three most frequent subclasses of pediatric-type diffuse high grade gliomas.

Balaguer-Lluna L, Olaciregui N, Aschero R, Resa-Pares C, Paco S, Cuadrado-Vilanova M J Neurooncol. 2025; .

PMID: 39961939 DOI: 10.1007/s11060-025-04954-w.


Targeted detection of sequence variants in cell-free DNA from cerebrospinal fluid in pediatric central nervous system tumors.

OHalloran K, Crotty E, Christodoulou E, Leary S, Miller A, Paulson V Front Oncol. 2025; 14():1513073.

PMID: 39834946 PMC: 11743934. DOI: 10.3389/fonc.2024.1513073.


Single-molecule systems for the detection and monitoring of plasma-circulating nucleosomes and oncoproteins in diffuse midline glioma.

Erez N, Furth N, Fedyuk V, Wadden J, Aittaleb R, Adam T Cell Rep Med. 2025; 6(1):101918.

PMID: 39809263 PMC: 11866549. DOI: 10.1016/j.xcrm.2024.101918.


Detection of tumor-derived cell-free DNA in cerebrospinal fluid using a clinically validated targeted sequencing panel for pediatric brain tumors.

Ronsley R, Karvonen K, Cole B, Paulson V, Stevens J, Crotty E J Neurooncol. 2024; 168(2):215-224.

PMID: 38755519 DOI: 10.1007/s11060-024-04645-y.


Procrustes is a machine-learning approach that removes cross-platform batch effects from clinical RNA sequencing data.

Kotlov N, Shaposhnikov K, Tazearslan C, Chasse M, Baisangurov A, Podsvirova S Commun Biol. 2024; 7(1):392.

PMID: 38555407 PMC: 10981711. DOI: 10.1038/s42003-024-06020-z.


References
1.
Marini B, Benitez L, Zureick A, Salloum R, Gauthier A, Brown J . Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors. Transl Res. 2017; 188:27.e1-27.e14. PMC: 5584679. DOI: 10.1016/j.trsl.2017.08.001. View

2.
Siravegna G, Geuna E, Mussolin B, Crisafulli G, Bartolini A, Galizia D . Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases. ESMO Open. 2017; 2(4):e000253. PMC: 5640139. DOI: 10.1136/esmoopen-2017-000253. View

3.
Connolly I, Li Y, Pan W, Johnson E, You L, Vogel H . A pilot study on the use of cerebrospinal fluid cell-free DNA in intramedullary spinal ependymoma. J Neurooncol. 2017; 135(1):29-36. PMC: 8451503. DOI: 10.1007/s11060-017-2557-y. View

4.
Pan W, Gu W, Nagpal S, Hayden Gephart M, Quake S . Brain tumor mutations detected in cerebral spinal fluid. Clin Chem. 2015; 61(3):514-22. PMC: 5412506. DOI: 10.1373/clinchem.2014.235457. View

5.
Hiemcke-Jiwa L, Minnema M, Radersma-van Loon J, Jiwa N, de Boer M, Leguit R . The use of droplet digital PCR in liquid biopsies: A highly sensitive technique for MYD88 p.(L265P) detection in cerebrospinal fluid. Hematol Oncol. 2017; 36(2):429-435. DOI: 10.1002/hon.2489. View